C
Charles B. Wilson
Researcher at University of California, San Francisco
Publications - 353
Citations - 26764
Charles B. Wilson is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Adenoma & Pituitary adenoma. The author has an hindex of 87, co-authored 353 publications receiving 26110 citations.
Papers
More filters
Journal ArticleDOI
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: A cooperative clinical trial
Walker,Eben Alexander,William E. Hunt,MacCarty Cs,Mahaley Ms,John Mealey,Norrell Ha,Owens G,Joseph Ransohoff,Charles B. Wilson,Gehan Ea,Strike Ta +11 more
TL;DR: An analysis of prognostic factors indicates that the initial performance status, age, the use of only a surgical biopsy, parietal location, the presence of seizures, or the involvement of cranial nerves II, III, IV, and VI are all of significance.
Journal ArticleDOI
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.
Walker,Sylvan B. Green,David P. Byar,Eben Alexander,Batzdorf U,Brooks Wh,William E. Hunt,MacCarty Cs,Mahaley Ms,John Mealey,Owens G,Ransohoff J nd,Robertson Jt,W. R. Shapiro,Smith Kr,Charles B. Wilson,Strike Ta +16 more
TL;DR: It is suggested that it is best to use radiotherapy in the post-surgical treatment of malignant glioma and to continue the search for an effective chemotherapeutic regimen to use in addition to radiotherapy.
Journal ArticleDOI
Normal perfusion pressure breakthrough theory.
Robert F. Spetzler,Charles B. Wilson,Phillip Weinstein,Max Mehdorn,Jeannette J. Townsend,Dave Telles +5 more
Journal ArticleDOI
Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E.
TL;DR: The three-dimensional structure of the LDL receptor-binding domain of apoE has been determined at 2.5 angstrom resolution by x-ray crystallography and provides the basis for understanding the behavior of naturally occurring mutants that can lead to atherosclerosis.
Journal Article
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.
Sylvan B. Green,David P. Byar,Walker,Pistenmaa Da,Eben Alexander,Batzdorf U,Brooks Wh,William E. Hunt,John Mealey,Odom Gl,Paoletti P,Ransohoff J nd,Robertson Jt,Selker Rg,W. R. Shapiro,Smith Kr,Charles B. Wilson,Strike Ta +17 more
TL;DR: It is indicated that BCNU and procarbazine are moderately useful agents in conjunction with radiotherapy for patients with malignant glioma and future protocols may allow use of corticosteroids in conventional dosages for treating cerebral edema and controlling symptoms.